An increasing number of studies has shown that the immune response mediated by T lymphocytes plays an important role in anti-tumor immunity.[7] Both Treg and Th17 cells are important subtypes of CD4+ T lymphocytes. This evidence concerns the gene CD4 and neoplasm.